Since Paxlovid became available seven months ago, it has eclipsed other available therapies created to forestall life-threatening COVID symptoms in high-risk patients. Some doctors are quick to prescribe it, but as with so much about the COVID pandemic, there is controversy. Some patients are concerned about a possible rebound of the disease, while others have difficulty convincing their doctors they are good candidates for the drug.
